We will assess the changes in plasmatic EV-derived BDNF concentrations after 4 weeks of rTMS treatment in PD-MCI patients relative to PD-MCI patients receiving sham rTMS treatment and those receiving no rTMS treatment. This evidence concerns the gene BDNF and Parkinson disease.